• Users Online: 275
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 4  |  Issue : 2  |  Page : 144-146

A severe case of neutropenia secondary to clopidogrel

1 CUNY York College PA Program; The Heart Center in Roslyn, St. Francis Hospital, New York, USA
2 The Heart Center in Roslyn, St. Francis Hospital, New York, USA

Correspondence Address:
Mr. Harrynauth Persaud
CUNY York College PA Program, New York
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jpcs.jpcs_21_18

Rights and Permissions

An 83-year-old male patient presented with complaints of generalized body aches, fever, rhinorrhea, and worsening dyspnea for the past 5 days. Four weeks ago, he was started on clopidogrel after he underwent stent placement to his left leg. Current admission laboratory findings revealed a white blood cell (WBC) count of 1180, with no neutrophils corresponding to an absolute neutrophil count of zero. After an extensive negative infectious workup, clopidogrel was determined to be the offending agent. This medication was discontinued and the patient was placed on a leukocyte growth factor with significant improvement in his WBC and neutrophil counts. On discharge, clopidogrel was replaced with ticagrelor. During post-discharge follow-up visits scheduled at 2 weeks and at 6 months, the patient continues to remain stable with blood counts back to baseline.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded154    
    Comments [Add]    
    Cited by others 1    

Recommend this journal